Fundraising Fox

Yvonne Yamanaka

Investor

Principal at venBio Partners

San Francisco, California

Writes $20M – $30M checks · typically $25M

About

Yvonne Yamanaka combines hands-on technical experience—she helped invent an immunotherapy platform as a graduate student and led its development at EMD/Merck Serono—and built companies from the whiteboard up at Flagship Pioneering.

Invests in

BiotechHealthtech

Experience

  1. venBio PartnersPartnercurrent2016 — presentSan Francisco Bay Area
  2. Flagship PioneeringAssociate2015 — 2016
  3. EMD Serono, Inc.Postdoctoral Fellow, Immuno-Oncology & Immuno-Technologies2014 — 2015
  4. Flagship PioneeringVentureLabs Fellow2014
  5. Massachusetts Institute of Technology (MIT)Ph.D., Biological Engineering2008 — 2014
  6. American Journal ExpertsContract Editor2012 — 2013

Education

  1. Massachusetts Institute of TechnologyDoctor of Philosophy (Ph.D.), Biological Engineering2008 — 2014
  2. Duke UniversityB.S.E., Biomedical Engineering2004 — 2008

Same school

Shared employers

Colleagues at venBio Partners

Network2

Investors connected to Yvonne in public investor directories — a warm-intro map.